EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Initial clinical experience with the novel POLARx FIT cryoballoon system for pulmonary vein isolation in patients with atrial fibrillation

Hiroshi Fukunaga, Yukio Sekiguchi, Jun Sawaguchi, Yosuke Hayashi, Sou Asano, Kei Mabuchi, Kanki Inoue, Kohei Tanizaki, Jun Umemura, Mitsuaki Isobe, Junichi Nitta

IJC Heart & Vasculature · 2024-02 · 50 · 101326

DOI: 10.1016/j.ijcha.2023.101326 ↗

Kurz gefasst

Fachartikel in der Zeitschrift IJC Heart & Vasculature, 2024-02. Verfasst von Hiroshi Fukunaga und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Sakakibara Heart Institute, 3-16-1 Asahi-cho, Tokyo 183-0003, Japan. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The POLARx FIT system (Boston Scientific, MA, USA) is a novel cryoballoon (CB) ablation technology in which the balloon diameter can be expanded from 28 to 31 mm. The aim of this study was to compare the benefits and safety of the new POLARx FIT system to those of the existing POLARx system currently in use for pulmonary vein (PV) isolation (PVI) in patients with atrial fibrillation.

Methods

The first 70 consecutive patients who underwent CB-based PVI with the POLARx FIT system were retrospectively compared with 200 consecutive patients treated with the POLARx system at Sakakibara Heart Institute from October 2021 to May 2023.

Results

The POLARx FIT system yielded a higher mean ± standard deviation nadir temperature in the right inferior PV (-59.2 ± 5.29 °C vs. - 62.0 ± 5.08 °C, p = 0.006), but this required a balloon size reduction to 28 mm in 30 % of cases. No significant differences were detected in the time to isolation and thaw time of any PV between the two groups. After the CB-based PVI procedure, no residual PV carina potentials were observed with the POLARx FIT system, whereas 4/20 were with the POLARx system (p = 0.04).

Conclusions

The POLARx FIT system had comparable effectiveness and safety to the basic POLARx system. This technology may improve the ablation area, including the PV carina. However, the 31-mm balloon alone was not sufficient to isolate certain PVs.

Schlagwörter

Stichwörter der Autor:innen

Atrial fibrillationCryoballoonPOLARx FIT systemPOLARx systemPulmonary vein isolation

Autor:innen und Institutionen

  • Department of Cardiology, Sakakibara Heart Institute, 3-16-1 Asahi-cho, Tokyo 183-0003, Japan.

Zitieren

APA

Fukunaga, H., Sekiguchi, Y., Sawaguchi, J., Hayashi, Y., Asano, S., Mabuchi, K., Inoue, K., Tanizaki, K., Umemura, J., Isobe, M., & Nitta, J. (2024). Initial clinical experience with the novel POLARx FIT cryoballoon system for pulmonary vein isolation in patients with atrial fibrillation. IJC Heart & Vasculature, 50, 101326. https://doi.org/10.1016/j.ijcha.2023.101326

Vancouver

Fukunaga H, Sekiguchi Y, Sawaguchi J, Hayashi Y, Asano S, Mabuchi K, et al. Initial clinical experience with the novel POLARx FIT cryoballoon system for pulmonary vein isolation in patients with atrial fibrillation. IJC Heart & Vasculature. 2024;50:101326. doi:10.1016/j.ijcha.2023.101326

BibTeX
@article{Fukunaga2024,
  author = {Fukunaga, Hiroshi and Sekiguchi, Yukio and Sawaguchi, Jun and Hayashi, Yosuke and Asano, Sou and Mabuchi, Kei and Inoue, Kanki and Tanizaki, Kohei and Umemura, Jun and Isobe, Mitsuaki and Nitta, Junichi},
  title = {Initial clinical experience with the novel POLARx FIT cryoballoon system for pulmonary vein isolation in patients with atrial fibrillation},
  journal = {IJC Heart & Vasculature},
  year = {2024},
  volume = {50},
  pages = {101326},
  doi = {10.1016/j.ijcha.2023.101326}
}
Kostenlos starten →